By Barbara Loe Fisher Scientists at the National Institutes of Health are working with a biotech company to quickly start clinical trials of an experimental messenger RNA vaccine and fast track it to licensure. 1 The FDA has not yet licensed messenger RNA vaccines that use part of the RNA of a virus to manipulate the body’s immune system into stimulating a potent immune response. 2 3  It looks like the coronavirus vaccine will be the first genetically engineered messenger RNA vaccine to be fast tracked to licensure, just like Gardasil was the first genetically…
